The 12th Invest in ME Conference, Part 1
OverTheHills presents the first article in a series of three about the recent 12th Invest In ME international Conference (IIMEC12) in London.
Discuss the article on the Forums.

Access to Data from Industry-Sponsored Clinical Trials

Discussion in 'Other Health News and Research' started by MeSci, Nov 7, 2014.

  1. MeSci

    MeSci ME/CFS since 1995; activity level 6?

    Cornwall, UK
    I couldn't find this article here - hope it hasn't already been posted.

    Data Sharing, Year 1 — Access to Data from Industry-Sponsored Clinical Trials
    Brian L. Strom, M.D., M.P.H., Marc Buyse, Sc.D., John Hughes, B.Sc., and Bartha M. Knoppers, Ph.D.

    October 15, 2014

    There has been considerable interest of late in increasing the transparency of clinical trials, including increasing access to the raw data from trials sponsored by the pharmaceutical industry.1 Since May 2013, investigators have been able to request access to deidentified patient-level data from clinical trials sponsored by GlaxoSmithKline,2 subject to review and oversight by an independent review panel ( As the members of this panel, we now have more than 12 months of experience with this initiative — and can report that it has been a productive and successful first step.

    Full article here.
    barbc56, Ren, Bob and 3 others like this.
  2. alex3619

    alex3619 Senior Member

    Logan, Queensland, Australia
    Transparency is the way to go.
    Ren, halcyon and MeSci like this.

See more popular forum discussions.

Share This Page